Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03IDU
|
||||
| Former ID |
DNC011939
|
||||
| Drug Name |
Hydrogen peroxide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Formula |
H2O2
|
||||
| Canonical SMILES |
[O-2].OO.[U]
|
||||
| InChI |
1S/H2O2.O.U/c1-2;;/h1-2H;;/q;-2;
|
||||
| InChIKey |
WMFCWGCIDZOWLY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| SuperDrug ATC ID |
A01AB02; D08AX01; S02AA06
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of Protein tyrosine phosphatase-1B | Target Info | Inhibitor | [525449] | |
| KEGG Pathway | Adherens junction | ||||
| Insulin signaling pathway | |||||
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Cadherin signaling pathway | ||||
| Pathway Interaction Database | Insulin Pathway | ||||
| Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | |||||
| Signaling events mediated by PTP1B | |||||
| Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
| Signaling events mediated by TCPTP | |||||
| IGF1 pathway | |||||
| EGF receptor (ErbB1) signaling pathway | |||||
| Posttranslational regulation of adherens junction stability and dissassembly | |||||
| PDGFR-beta signaling pathway | |||||
| N-cadherin signaling events | |||||
| References | |||||
| Ref 539576 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2448). | ||||
| Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.